x

Zoek een klinische studie of trial

* (*) verplicht veld

43 Resultaat/Resultaten

Aanwerving proef = Aanwerving proef
; Lopend onderzoek = Lopend onderzoek
; Gefinancierd door een IRDiRC-lid = ; Member of a ERN =

Nationale klinische studie(s)

DUITSLAND

Bayern
MÜNCHEN

FRANKRIJK

ILE-DE-FRANCE
PARIS

FRANKRIJK

ILE-DE-FRANCE
PARIS

SNT-III-001 MICONOS. A Phase III double blind, randomised, placebo-controlled study of the efficacy, safety and tolerability of Idebenone in the treatment of Friedreich Ataxia
Institut du Cerveau et de la Moelle épinière (ICM) - Hôpital Pitié-Salpêtrière
Equipe "Bases moléculaires, physiopathologie et traitement des maladies neurodégénératives"

FRANKRIJK

ILE-DE-FRANCE
PARIS

MICONOS Extension : A Phase III Open-Label, Single-Group, Extension Study to Obtain Long-Term Safety and Tolerability Data of Idebenone in the Treatment of Friedreich's Ataxia Patients - FR
Institut du Cerveau et de la Moelle épinière (ICM) - Hôpital Pitié-Salpêtrière
Equipe "Bases moléculaires, physiopathologie et traitement des maladies neurodégénératives"

ITALIË

VENETO
PADOVA

DELOS: A Phase III Double-Blind, Randomised, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of Idebenone in 10,18 Year Old Patients with Duchenne Muscular Dystrophy - IT
Azienda Ospedaliera Universitaria di Padova - Campus Biomedico Pietro d'Abano
Laboratorio di Istomorfologia e Biologia Molecolare del Rene

OOSTENRIJK

STEIERMARK
GRAZ

VERENIGD KONINKRIJK

Greater London
LONDON

VERENIGD KONINKRIJK

Tyne & Wear
NEWCASTLE UPON TYNE

A Double-Blind, Randomised, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of Idebenone in the Treatment of Patients With Leber's Hereditary Optic Neuropathy (Phase II)
Newcastle University Institute for Ageing (NUIA), Newcastle Biomedicine
Wellcome Trust Centre for Mitochondrial Research (Institute of Neuroscience)

Multinationale klinische studie(s)